Dr. Bernard De Bruyne

Bernard De Bruyne

Interventional cardiologist / Cardiologist
Cardiovascular Center Aalst - Aalst, Belgium

Recognizing the practical impact of pressure-derived FFR for appropriate targeting of stenting, his entire career has been devoted to accumulating proof of evidence for its clinical usefulness.

Latest contributions

LAA closure

19 May 2017 – From EuroPCR 2017

Consult this session on LAA closure, that includes a LIVE demonstration from the Cardiovascular Centre, OLV Aalst - Aalst, Belgium.

Coronary interventions LIVE demonstration: complex left main PCI

19 May 2017 – From EuroPCR 2017

Montreal Live@EuroPCR - Management of a multivessel disease patient at high bleeding risk

18 May 2017 – From EuroPCR 2017

Application of the ILUMIEN III PCI optimisation criteria in the real world

18 May 2017 – From EuroPCR 2017

The prognostic value of FFR: linking physiologic severity to clinical outcomes

19 May 2015 – From EuroPCR 2015

Prof. Nico H. Pijls

Chairperson

Nico H.j. Pijls

Imaging and functional assessment

18 May 2016 – From EuroPCR 2016

Panellists: J.J. Bax, C. Kyriakakis, M. Monaghan, L. Räber, H. Samady and R. Waksman

Watch the video on imaging and functional assessment from the Session comprising of selected EuroPCR 2016 Cardiovascular innovation pipeline submissions.

Dr. Bernard De Bruyne

Chairperson

Bernard De Bruyne
Dr. Javier Escaned

Chairperson

Javier Escaned

Cardiovascular innovation pipeline - Imaging and physiology

22 May 2015 – From EuroPCR 2015

Integrating coronary anatomy and physiology: advances in co-registration techniques

21 May 2015 – From EuroPCR 2015

Prof. Ran Kornowski

Chairperson

Ran Kornowski

DES, bare-metal or bioactive stent: which stent to use to treat ACS patients? OPTIMAX the third way (third-generation bioactive stent)

21 May 2015 – From EuroPCR 2015

Planned and ongoing clinical trials: a status update from genae

22 May 2014 – From EuroPCR 2014

Chairperson

Alexandra Lansky

Chairperson

Bart Segers

Value of FFR guidance in complex clinical and anatomical subsets

22 May 2014 – From EuroPCR 2014

First experience of the third generation titanium-nitride-oxide bioactive stent Titan Optimax: a new horizon in angioplasty

21 May 2014 – From EuroPCR 2014